Global Military Products Secures Major $639.8M Artillery Contract

Author: Evelyn Baker Updated: 09-25-2025 06:59 PM

Global Military Products Achieves Significant Supply Contract

Global Military Products (GMP) has recently secured a substantial contract worth $639.8 million from the U.S. Army. This contract signifies GMP's vital role as a dependable supplier of munitions and showcases its ongoing collaboration with Rheinmetall Expal Munitions.

Contract Overview and Importance

This contract is specifically aimed at the procurement of 155mm High Explosive complete rounds, aligning with the U.S. Army's Special Ammunitions and Weapons Systems program. The firm-fixed-price nature of this agreement underscores the Army's commitment to obtaining reliable and effective ammunition solutions.

Key Statements by Company Officials

Mike Quesenberry, Vice President of Ammunition Programs and Engineering at GMP, expressed satisfaction with the contract win, stating, "This represents a significant win for GMP and showcases our support of U.S. Army requirements in bringing innovative solutions to our customers." This statement emphasizes GMP's dedication to fulfilling the evolving needs of military operations.

Timeline for Production

GMP is set to initiate production in 2026, with a projected completion date aimed for July 10, 2027. This timeline is a testament to GMP's organizational capacity and commitment to timely delivery of high-quality munitions.

Impact on U.S. Military Operations

The awarding of this contract fortifies GMP's position as a trusted prime contractor within the Department of War, reflecting their deep commitment to enabling the operational readiness of the U.S. Army. Such partnerships are instrumental not just for logistics but for the overall effectiveness of military strategies deployed globally.

Company Background

Global Military Products operates under the umbrella of Global Ordnance Holdings and is recognized as a prime contractor for the Department of War. Based in Florida, GMP specializes in supplying a wide array of military needs, including weapons, ammunition, and critical supplies to U.S. allies globally. The existing relationships with partners like Rheinmetall Expal Munitions enhance their service offerings and operational scope.

GMP's Commitment to Quality

Quality assurance is a cornerstone of GMP’s mission. The company adopts stringent quality control measures to ensure that all products meet the highest standards required by the U.S. Army and its allies. This dedication to excellence has earned GMP a stellar reputation in the defense contracting industry.

Future Prospects

Looking ahead, GMP aims to further broaden its scope of operations and strengthen partnerships that align with its strategic goals. The successful execution of this contract can pave the way for future opportunities, not only within the U.S. but also in international markets.

Frequently Asked Questions

What is the value of the contract awarded to GMP?

The contract awarded to Global Military Products is valued at $639.8 million.

What type of munitions will GMP supply?

GMP will supply 155mm High Explosive complete rounds.

When is the production scheduled to begin?

Production is set to commence in 2026.

Who is the Vice President of Ammunition Programs at GMP?

Mike Quesenberry is the Vice President of Ammunition Programs and Engineering at GMP.

What is the mission of Global Military Products?

GMP's mission is to provide reliable ammunition and military supplies to support U.S. Army missions worldwide.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.